Evaluation of visfatin levels in patients with multiple sclerosis

Key Points

• Higher visfatin levels correlate with increased inflammation in multiple sclerosis patients, indicating a potential biomarker.
• Increased levels of visfatin were observed in this patient population, highlighting its relevance for monitoring immune responses.
• Analysis of blood samples from multiple sclerosis patients was conducted to assess visfatin levels and their implications.
• Findings may enable better understanding of inflammatory processes in multiple sclerosis, challenging existing treatment approaches.